Shannon James Samuel Insider Trades

Insider Trading History

Track insider trading activity for Shannon James Samuel. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $44.5k 5,000 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40k 5,000 shares
$7.99
$8.90
Mannkind
Mannkind MNKD
Director
Holding Value $325k 82,781 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$323k 99,337 shares
$3.25
$3.93
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $89k 10,000 shares
Last Trade
Mar 26, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$44k 5,000 shares
$8.79
$8.90
ProQR Therapeutics N.V
ProQR Therapeutics N.V PRQR
Director
Holding Value $116k 61,538 shares
Last Trade
Mar 18, 2026 Sale
$469k 272,853 shares
$1.72
$1.89
Mannkind
Mannkind MNKD
Director
Holding Value $254k 64,635 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.2k 12,000 shares
$3.27
$3.93
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $623k 70,000 shares
Last Trade
Jun 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.3k 25,000 shares
$0.69
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $401k 45,000 shares
Last Trade
Jun 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.1k 45,000 shares
$0.69
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $276k 31,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.4k 31,000 shares
$0.69
$8.90
Mannkind
Mannkind MNKD
Director
Holding Value $208k 52,854 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 52,854 shares
$4.57
$3.93
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $445k 50,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.5k 50,000 shares
$1.05
$8.90
Mannkind
Mannkind MNKD
Director
Holding Value $138k 35,047 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 35,047 shares
$4.45
$3.93
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Director
Holding Value $0 0 shares
Last Trade
Oct 06, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.44M 63,949 shares
$116.30
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Director
Holding Value $3.86M 33,156 shares
Last Trade
Sep 29, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.37M 11,850 shares
$115.69
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Director
Holding Value $948k 8,150 shares
Last Trade
Sep 29, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.37M 11,850 shares
$115.69
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Director
Holding Value $467k 4,016 shares
Last Trade
Jul 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 4,016 shares
$99.60
$116.30
Mannkind
Mannkind MNKD
Director
Holding Value $186k 47,393 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$216k 47,393 shares
$4.55
$3.93
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Director
Holding Value $0 0 shares
Last Trade
Apr 28, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$435k 3,913 shares
$111.16
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Director
Holding Value $2.7M 23,185 shares
Last Trade
Apr 28, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$435k 3,913 shares
$111.16
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Director
Holding Value $2.48M 21,306 shares
Last Trade
Apr 28, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$209k 1,879 shares
$111.16
$116.30
Mannkind
Mannkind MNKD
Director
Holding Value $177k 45,045 shares
Last Trade
May 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 45,045 shares
$2.95
$3.93

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up